Schizophrenia: 2025 Statistics

Schizophrenia affects millions around the world—but many go without the care they need. This guide breaks down global and U.S. statistics on who’s affected, how the condition impacts life expectancy and disability, and what’s being done to close the treatment gap and offer hope for recovery.

Back to Top
Schizophrenia is a serious, chronic mental disorder characterised by significant disruptions in thought, perception, and emotional responsiveness. While it is a relatively rare condition, its impact on individuals and society is profound, leading to severe disability and a drastically reduced life expectancy.
The headline statistic reveals this stark reality: the estimated average potential life lost for an individual with schizophrenia is 28.5 years. This is not just a number; it represents decades of life lost to preventable physical illnesses and a higher risk of suicide, underscoring schizophrenia's status as a critical public health issue.
- Overall Prevalence and General Numbers
- Breakdown by Key Demographics
- Co-occurrence and Related Conditions
- The Most Serious Consequences
- The Positive Outlook and Solutions
- Conclusion
- Sources
Overall Prevalence and General Numbers
- Global Prevalence: An estimated 24 million people , or 1 in 300 (0.32%), live with schizophrenia worldwide.
- Adult Prevalence: Among adults, the global prevalence is higher, affecting 1 in 222 people (0.45%).
- U.S. Prevalence: In the United States, the prevalence of schizophrenia and related psychotic disorders is estimated to be between 0.25% and 0.64% of the population.
- A Leading Cause of Disability: Schizophrenia is one of the top 15 leading causes of disability worldwide.
Breakdown by Key Demographics
- Age of Onset: The disorder is most often diagnosed in late adolescence and the early twenties.
- By Gender: While overall prevalence is similar, schizophrenia tends to emerge earlier in males (late teens to early twenties) than in females (early twenties to early thirties).
Co-occurrence and Related Conditions
- Co-occurring Mental Disorders: Approximately half of all individuals with schizophrenia have co-occurring mental and/or behavioural health disorders.
- Physical Health Conditions: People with schizophrenia are more likely to have co-occurring physical conditions like heart disease, liver disease, and diabetes.
- Substance Use: Heavy use of substances, particularly cannabis, is associated with an elevated risk of developing the disorder.
The Most Serious Consequences
- Premature Mortality: People with schizophrenia are 2 to 3 times more likely to die early than the general population, largely due to preventable physical illnesses that go undertreated.
- Suicide Risk: An estimated 4.9% of people with schizophrenia die by suicide —a rate far greater than in the general population. The risk is highest in the early stages of the illness.
- Stigma and Human Rights: Individuals often experience intense stigma and discrimination, which limits their access to housing, employment, and education and can lead to human rights violations.
The Positive Outlook and Solutions
- Hope for Recovery: With effective treatment, at least one-third of people with schizophrenia experience complete remission of their symptoms. Effective care options include medication, psychotherapy, and psychosocial rehabilitation like life skills training.
- The Global Treatment Gap: A significant majority of people with schizophrenia are not receiving care. Globally, only 31.3% of people with psychosis receive specialist mental health care.
- Inefficient Care Models: Most resources are inefficiently spent on long-term care in mental hospitals. The World Health Organisation emphasises a shift toward community-based services that are more effective and rights-oriented.
Conclusion
The statistics show that schizophrenia is a severe, disabling disorder that drastically shortens lives and is compounded by stigma and a massive global treatment gap. Yet, the data also offers a clear message of hope: recovery is attainable for a significant portion of individuals. Closing the gap between the number of people who need help and those who receive it is the most critical step toward improving outcomes and restoring years of life for millions worldwide.
Sources
- World Health Organisation (WHO). (2022, January 10). Schizophrenia.
- National Institute of Mental Health (NIMH). (n.d.). Schizophrenia Statistics.
- PubMed Central. “Follow-Up Studies Have Estimated That Between 50% and 70% of Individuals With Schizophrenia Experience Relapse During Their Lifetime.” Schizophrenia Research, vol. 82, no. 2–3, 2006. PMC1845151.
Important:
TherapyRoute does not provide medical advice. All content is for informational purposes and cannot replace consulting a healthcare professional. If you face an emergency, please contact a local emergency service. For immediate emotional support, consider contacting a local helpline.